Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Rayvow
RAYVOW is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.
